News
Zeotap builds momentum as marketing industry shifts away from cookies
Zeotap, the Customer Intelligence Platform (CIP), has reported 126% ARR growth in 2020 among its latest milestones in growth. Building momentum from its $60.5 million Series C fundraising round last year, the company is capitalizing on the marketing industry’s move to better engage first-party data in the face of the
Read MoreAchronix now shipping industry’s highest performance Speedster7t FPGA devices
Achronix Semiconductor Corporation, a leader in high-performance FPGAs and embedded FPGA (eFPGA) IP, today announced that it has begun shipping its 7nm Speedster®7t AC7t1500 FPGAs to customers ahead of schedule. The Speedster7t family is purpose-built for high bandwidth workloads in a broad range of applications including AI/ML, 5G infrastructure, networking,
Read MoreABL Space raises $170m growth equity round led by T. Rowe Price funds
ABL Space Systems has closed a Series B investment round of $170 million at a valuation of $1.3 billion. The round was led by funds and accounts advised by T. Rowe Price Associates, Inc. Participation in the round included existing ABL investors and new investments by Fidelity Management & Research
Read MoreVentyx Biosciences doses first subject in a Phase 1 Trial of VTX-958, a selective allosteric TYK2 Inhibitor for Autoimmune Diseases
Ventyx Biosciences, Inc. a clinical-stage biotechnology company developing oral, small molecule therapeutics for autoimmune disease, today announced the dosing of the first subject in a Phase 1 clinical trial of VTX-958, a novel and selective allosteric TYK2 inhibitor. In non-clinical studies, VTX-958 has shown potential to treat autoimmune diseases by
Read MoreNew Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million
New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline of immunology programs. Ventyx Biosciences combines assets from three formerly
Read MoreiCAD – New research supporting ProFound AI presented at European congress of radiology online meeting
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new research supporting ProFound AI® was presented at the European Congress of Radiology (ECR) 2021 Online meeting, taking place March 3-10, 2021. During the congress, the Company also showcased the full suite
Read MoreIsorg obtains FBI certification for security market’s first organic photodiode-based module for fingerprint scanners
Isorg, a pioneer in organic photodetectors (OPDs) and large-area image sensors, today announces its Fingerprint Acquisition Profile (FAP) 10 module has received FBI certification, the first in this category of organic photodiode (OPD) based optical sensors. The FAP 10 biometrics module is now approved for use in security applications, in
Read MoreiCAD announces closing of $25.0 million public offering of common stock and full exercise of underwriters’ option to purchase additional shares
iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the closing on March 5, 2021 of its previously announced underwritten public offering of 1,393,738 shares of common stock at a public offering price of $18.00 per share, which included
Read MoreDataCore Software acquires Caringo, Inc.
DataCore Software, the authority on software-defined storage, today announced that it has acquired Caringo, Inc. The combined entity will enable DataCore to offer complete, best-of-breed software-defined storage solutions for block, file, and object—from a single vendor. The acquisition will also add talent and expertise to the DataCore team, as well
Read MoreNew Science Ventures announces merger of its portfolio company Achronix with ACE Convergence
New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, today announces the merger of its portfolio company, Achronix Semiconductor Corporation (“Achronix”), with ACE Convergence Acquisition Corp. NSV is a founding investor in Achronix. Highlights: Achronix is the
Read MoreNorthSea Therapeutics reports Positive Phase 2b interim results for icosabutate in NASH patients
NorthSea Therapeutics B.V., (‘NST’) a Dutch biotech company developing novel and innovative therapies for NASH (Non-alcoholic Steatohepatitis) and other metabolic, inflammatory, and fibrotic diseases based on its SEFA (Structurally Engineered Fatty Acid) technology, today announced a positive interim readout of its ICONA Phase 2b study. The ICONA study (ICOsabutate in
Read MoreTigerConnect acquires Critical Alert
TigerConnect®, healthcare’s most advanced, reliable, and widely adopted care team collaboration solution, today announced the acquisition of Critical Alert®, a leading provider of enterprise-grade middleware for hospitals and health systems. Critical Alert’s product suite consists of a middleware suite of products as well as traditional nurse call hardware servicing over
Read More